RevMAb Biosciences' Unattributed Round

RevMAb Biosciences raised a round of funding on March 21, 2013.

RevMAb Biosciences USA has developed a monoclonal antibody generation method which allows development of monoclonal antibodies without generation of hybridoma. The antibodies are developed from a broa…

Articles about RevMAb Biosciences' Unattributed Round: